SPR965, a Dual PI3K/mTOR Inhibitor, as a Targeted Therapy in Ovarian Cancer.

Tran AQ, Sullivan SA, Chan LL, Yin Y, Sun W, Fang Z, Dugar S, Zhou C, Bae-Jump V

Open source

DOI: 10.3389/fonc.2020.624498
Published: 2020
Container: Frontiers in oncology
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/fonc.2020.624498,
  title = {SPR965, a Dual PI3K/mTOR Inhibitor, as a Targeted Therapy in Ovarian Cancer.},
  author = {Tran AQ and Sullivan SA and Chan LL and Yin Y and Sun W and Fang Z and Dugar S and Zhou C and Bae-Jump V},
  year = {2020},
  journal = {Frontiers in oncology},
  doi = {10.3389/fonc.2020.624498},
  url = {https://doi.org/10.3389/fonc.2020.624498}
}

RIS

TY  - JOUR
TI  - SPR965, a Dual PI3K/mTOR Inhibitor, as a Targeted Therapy in Ovarian Cancer.
AU  - Tran AQ
AU  - Sullivan SA
AU  - Chan LL
AU  - Yin Y
AU  - Sun W
AU  - Fang Z
AU  - Dugar S
AU  - Zhou C
AU  - Bae-Jump V
PY  - 2020
JO  - Frontiers in oncology
DO  - 10.3389/fonc.2020.624498
UR  - https://doi.org/10.3389/fonc.2020.624498
ER  -

APA

AQ, T., SA, S., LL, C., Y, Y., W, S., Z, F., S, D., C, Z., & V, B. (2020). SPR965, a Dual PI3K/mTOR Inhibitor, as a Targeted Therapy in Ovarian Cancer.. Frontiers in oncology. https://doi.org/10.3389/fonc.2020.624498

Source records

pubmed · retrieved 2026-09-27T17:44:20.381Z
europe-pmc · retrieved 2026-09-27T17:44:20.395Z
doaj · retrieved 2026-09-27T17:44:20.392Z